Mairs & Power Inc Baxter International Inc Transaction History

Mairs & Power Inc

$10.3 Billion
Q2 2024

A detailed history of Mairs & Power Inc transactions in Baxter International Inc stock. As of the latest transaction made, Mairs & Power Inc holds 61,308 shares of BAX stock, worth $2.41 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

61,308

Previous 80,324 23.67%

Holding current value

$2.41 Million

Previous $3.43 Million 40.29%

% of portfolio

0.02%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$32.87 - $43.55 $625,055 - $828,146	-19,016 Reduced 23.67%	61,308 $2.05 Million
Q1 2024 May 15, 2024	SELL	$37.88 - $43.77 $1.54 Million - $1.78 Million	-40,629 Reduced 33.59%	80,324 $3.43 Million
Q4 2023 Feb 14, 2024	SELL	$31.71 - $38.95 $1.78 Million - $2.19 Million	-56,235 Reduced 31.74%	120,953 $4.68 Million
Q3 2023 Nov 14, 2023	SELL	$37.32 - $49.29 $1.66 Million - $2.19 Million	-44,377 Reduced 20.03%	177,188 $6.69 Million
Q2 2023 Aug 14, 2023	SELL	$39.98 - $47.68 $1.26 Million - $1.5 Million	-31,395 Reduced 12.41%	221,565 $10.1 Million
Q1 2023 May 15, 2023	SELL	$37.58 - $52.57 $2.68 Million - $3.75 Million	-71,340 Reduced 22.0%	252,960 $10.3 Million
Q4 2022 Feb 14, 2023	SELL	$49.7 - $57.71 $9.69 Million - $11.2 Million	-194,887 Reduced 37.54%	324,300 $16.5 Million
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $50,736 - $62,925	942 Added 0.18%	519,187 $28 Million
Q2 2022 Aug 15, 2022	BUY	$63.83 - $80.0 $243,639 - $305,360	3,817 Added 0.74%	518,245 $33.3 Million
Q1 2022 May 16, 2022	SELL	$76.85 - $89.45 $156,774 - $182,478	-2,040 Reduced 0.39%	514,428 $39.9 Million
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $4.44 Million - $5.19 Million	-59,496 Reduced 10.33%	516,468 $44.3 Million
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $122,753 - $139,127	1,664 Added 0.29%	575,964 $46.3 Million
Q2 2021 Aug 16, 2021	SELL	$80.5 - $88.01 $416,990 - $455,891	-5,180 Reduced 0.89%	574,300 $46.2 Million
Q1 2021 May 14, 2021	SELL	$76.38 - $86.03 $1.37 Million - $1.55 Million	-17,978 Reduced 3.01%	579,480 $48.9 Million
Q4 2020 Feb 16, 2021	SELL	$75.39 - $82.36 $377,854 - $412,788	-5,012 Reduced 0.83%	597,458 $47.9 Million
Q3 2020 Nov 16, 2020	BUY	$78.33 - $90.73 $682,489 - $790,530	8,713 Added 1.47%	602,470 $48.5 Million
Q2 2020 Aug 14, 2020	SELL	$78.66 - $94.14 $816,569 - $977,267	-10,381 Reduced 1.72%	593,757 $51.1 Million
Q1 2020 May 15, 2020	SELL	$71.57 - $93.3 $394,207 - $513,896	-5,508 Reduced 0.9%	604,138 $49.1 Million
Q4 2019 Feb 14, 2020	SELL	$76.7 - $88.45 $215,143 - $248,102	-2,805 Reduced 0.46%	609,646 $51 Million
Q3 2019 Nov 14, 2019	SELL	$81.4 - $89.78 $568,497 - $627,023	-6,984 Reduced 1.13%	612,451 $53.6 Million
Q2 2019 Aug 14, 2019	SELL	$73.44 - $82.41 $3.33 Million - $3.74 Million	-45,362 Reduced 6.82%	619,435 $50.7 Million
Q1 2019 May 15, 2019	SELL	$64.48 - $81.31 $4.03 Million - $5.08 Million	-62,512 Reduced 8.59%	664,797 $54.1 Million
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $141,335 - $178,940	-2,300 Reduced 0.32%	727,309 $47.9 Million
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $911,239 - $1 Million	-12,887 Reduced 1.74%	729,609 $56.2 Million
Q2 2018 Aug 14, 2018	SELL	$63.43 - $75.41 $4.2 Million - $4.99 Million	-66,136 Reduced 8.18%	742,496 $54.8 Million
Q1 2018 May 15, 2018	SELL	$62.56 - $72.26 $15.1 Million - $17.4 Million	-241,447 Reduced 22.99%	808,632 $52.6 Million
Q4 2017 Feb 14, 2018	SELL	$61.45 - $66.05 $7.15 Million - $7.69 Million	-116,421 Reduced 9.98%	1,050,079 $67.9 Million
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $69.4 Million - $75.4 Million	1,166,500	1,166,500 $73.2 Million

Others Institutions Holding BAX

# of Institutions

981

Shares Held

446M

Call Options Held

2.22M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.

Account